News

SMS Pharmaceuticals Limited informed the BSE Limited and National Stock Exchange of India Ltd. that the company`s 38th Annual General Meeting, previously scheduled for Wednesday, September 23, 2026, will now be held on Tuesday, September 29, 2026, via video conferencing or other audio-visual means, with a record date for dividend eligibility set for Tuesday, September 22, 2026, and a book closure from Wednesday, September 23, 2026, to Tuesday, September 29, 2026.

SMS Pharmaceuticals announced that the 38th Annual General Meeting(AGM) of the company will be held on 23 September 2026.

Net profit of SMS Pharmaceuticals rose 2.05% to Rs 20.91 crore in the quarter ended June 2026 as against Rs 20.49 crore during the previous quarter ended June 2025. Sales rose 5.56% to Rs 206.96 crore in the quarter ended June 2026 as against Rs 196.05 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales206.96196.05 6 OPM %19.7920.08 - PBDT37.2034.12 9 PBT27.2124.37 12 NP20.9120.49 2 Powered by Capital Market - Live News

SMS Pharmaceuticals has revised the meeting of the Board of Directors which was scheduled to be held on 1 August 2026. The meeting will now be held on 31 July 2026.

SMS Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 1 August 2026.